Clinical trial
Evaluation of the Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli Isolated From Assiut University Hospitals
NCT07482553 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli Isolated From Assiut University Hospitals
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- June 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biofilm formation by uropathogenic escherichia coli (upec), catheter-associated urinary tract infections (cautis), urinary tract infections (utis)